Efficacy of intravenous thrombolysis according to stroke subtypes: The Madrid Stroke Network data

European Journal of Neurology

Volumn 19, Issue 12, 2012, Pages 1568-1574

  Fuentes, B ^a   Martinez Sanchez P ^a   de Leciñana, M Alonso ^b   Egido, J ^c   Reig Rosello G ^d   Diaz Otero F ^e   Sanchez V ^b   Simal, P ^c   Ximenez Carrillo, A ^d   Garcia Pastor A ^e   Ruiz Ares, G ^a   Garcia Garcia A ^c   Masjuan, J ^b   Vivancos Mora, J ^d   Gil Nunez A ^e   Diez Tejedor E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acute stroke; Intravenous thrombolysis; Ischaemic stroke; Stroke subtypes

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGE; AGED; ARTERY DIAMETER; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; SPAIN; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RECOVERY OF FUNCTION; REGISTRIES; SPAIN; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84869499693     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03790.x     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis - not a panacea for ischemic stroke. N Engl J Med 1997; 337: 1309-1310.
3. Cocho D, Belvís R, Martí-Fàbregas J, et al. Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol 2006; 55: 70-73.
4. Mustanoja S, Meretoja A, Putaala J, et al. Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke 2011; 42: 102-106.
5. Fluri F, Hatz F, Rutgers MP, et al. Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. Eur J Neurol 2010; 17: 1054-1060.
6. Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC. Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 2003; 61: 71-75.
7. Paciaroni M, Balucani C, Agnelli G, et al. Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: the ICARO study. Stroke 2012; 43: 125-130.
8. de Leciñana-Cases MA, Gil-Núñez A, Díez-Tejedor E. Relevance of stroke code, stroke unit and stroke networks in organization of acute stroke care - the Madrid acute stroke care program. Cerebrovasc Dis 2009; 27(Suppl 1): 140-147.
9. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
10. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309.
11. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
12. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004; 35: 486-490.
13. Köhrmann M, Nowe T, Huttner HB, et al. Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis 2009; 27: 160-166.
14. Khatri P, Conaway MR, Johnston KC. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 2012; 43: 560-562.
15. Kimura K, Iguchi Y, Shibazaki K, Sakamoto Y, Watanabe M. Intravenous tissue plasminogen activator thrombolysis in patients without major arterial occlusion seems to be safe and effective. Eur Neurol 2010; 64: 258-264.